Skip to content

Social Connectedness Group Intervention in Depression

Feasibility Study of the Groups for Health Intervention for Adults Accessing Treatment for Depression

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03446963
Acronym
G4H-A
Enrollment
29
Registered
2018-02-27
Start date
2018-10-01
Completion date
2019-03-18
Last updated
2019-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Brief summary

This study evaluates the feasibility of the Groups for Health (G4H) intervention for adults accessing support for depression in the UK. G4H targets improvements in adults' interpersonal functioning in order to reduce feelings of loneliness. The study will adapt the G4H intervention for delivery to adults seeking treatment for depression in the UK and estimate trial parameters (recruitment, retention, missing data and acceptability) of the adapted intervention, prior to a definitive trial. A mixed methods design of interviews and a single group, pre-post study will be employed.

Detailed description

Background: Loneliness is frequently reported amongst adults with depression. Interventions to reduce loneliness in different populations have shown mixed results. The Groups for Health (G4H) programme has been developed according to the social identity approach within social psychology and has demonstrated preliminary efficacy for reducing loneliness in a proof-of-concept study conducted with Australian student sample. The present study will examine whether G4H can be adapted to suit the needs of a clinical population in the context of UK secondary care services. Objective: Phase 1 - To adapt the G4H intervention for delivery to adults seeking treatment for depression in the UK. Phase 2: To estimate trial parameters (recruitment, retention, missing data and acceptability) of the adapted intervention, prior to a definitive trial; to optimise the adapted intervention for delivery to adults accessing treatment for depression in the UK; to optimise evaluation procedures (candidate outcome measures) Trial configuration: sequential exploratory mixed methods design. Phase 1: one-to-one interviews. Phase 2: Activity 1 (intervention), single group, pre-post study. Activity 2 (interviews): one-to-one interviews. Condition: Depression Interventions: group-based behavioural programme

Interventions

BEHAVIORALGroups for Health

Group sessions, 5 modules x 1.5 hours (once per week). Modules focus on psychoeducation, mapping existing social networks, examining barriers to engagement in existing networks, goal setting and identifying new groups to join.

Sponsors

University of Nottingham
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

Phase 1 Service user participants: * Aged 18-65 * Accessing treatment for depression * Loneliness: score 6 or above on the University of California Loneliness Scale (UCLA-3) (Hughes et al., 2004) * Able to speak/read English * Ability to give informed consent Staff participants: \- Clinical practitioner with at least 6 months experience of working with people with depression Phase 2 Activity 1: intervention * Aged 18-65 * Accessing treatment for depression * Loneliness: score 6 or above on the University of California Loneliness Scale (UCLA-3) (Hughes et al., 2004) * Able to speak/read English * Ability to give informed consent Activity 2: interviews \- Attended or agreed to attend Phase 2, Activity 1

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of recruitment3 monthsThe proportion of patients contacted for screening against those who are consented
Feasibility of enrollment3 monthsThe proportion of patients consented against those enrolled
Feasibility of data collection8 weeksThe overall proportion of survey measures completed by each participant at each of the 2 time points
Patient retention8 weeksThe proportion of patients attending all five G4H sessions

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026